BLUEPRINT MEDICINES CORP earnings per share and revenue

2L9 earnings per share for the last quarter are 1.34 EUR whereas the estimation was -1.54 EUR which accounts for 187.01% surprise. Företagets omsättning för samma period uppgår till 89.08 M EUR trots den uppskattade siffran 74.97 M EUR. Estimated earnings per share for the next quarter are -1.21 EUR, and revenue is expected to reach 95.87 M EUR. Also watch annual changes over time to get a bigger picture of 2L9 earnings per share and revenue dynamics.